List of Studies ( Metabolite:2-Methylene-4-oxopentanedioic acid)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
|---|---|---|---|---|---|---|---|
| ST002759 | AN004480 | Metabolic responses of normal rat kidneys to a high salt intake (Kidney cortex) | Kidney cortex | Rat | Medical College of Wisconsin | Area | |
| ST002761 | AN004487 | Metabolic responses of normal rat kidneys to a high salt intake (Urine) | Urine | Rat | Medical College of Wisconsin | Area | |
| ST003085 | AN005045 | Metabolome changes in embryonic CSF (Part 7) | CSF | Mouse | Autism | Boston Children's Hospital, Harvard Medical School | a.u. |
| ST002016 | AN003284 | Metabolomics of COVID patients | Blood | Human | COVID-19 | University of Virginia | intensity |
| ST002094 | AN003420 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | raw intensity |
| ST002094 | AN003422 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | raw intensity |
| ST000046 | AN000078 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Blood | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
| ST000047 | AN000080 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | Raw MS Intensities |
